Treatment as long-term prevention: Sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda

AIDS

Volumn 28, Issue 2, 2014, Pages 267-271

  Siedner, Mark J ^a   Musinguzi, Nicholas ^b   Tsai, Alexander C ^a   Muzoora, Conrad ^b   Kembabazi, Annet ^b   Weiser, Sheri D ^c   Bennett, John ^c   Hunt, Peter W ^c   Martin, Jeffrey N ^c   Haberer, Jessica E ^a   Bangsberg, David R ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Antiretroviral therapy; HIV AIDS; Sub Saharan Africa; Treatment as prevention; Uganda

Indexed keywords

EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE;

ADULT; AIDS PATIENT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL EVALUATION; CLINICAL RESEARCH; COHORT ANALYSIS; CONTROLLED STUDY; DRUG UTILIZATION; ENDEMIC DISEASE; FEMALE; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; RISK REDUCTION; RNA VIRUS; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; UGANDA; VIREMIA; VIRUS LOAD;

ADULT; ANTI-RETROVIRAL AGENTS; CHEMOPREVENTION; COHORT STUDIES; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; RURAL POPULATION; SEXUAL BEHAVIOR; UGANDA; VIRAL LOAD;

EID: 84892372975     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000136     Document Type: Article

References (20)

1. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23:1397-1404.
2. Reynolds SJ, Makumbi F, Nakigozi G, Kagaayi J, Gray RH, Wawer M, et al. HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy. AIDS 2011; 25:473-477.
3. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
4. Eaton JW, Johnson LF, Salomon JA, Barnighausen T, Bendavid E, Bershteyn A, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med 2012; 9:e1001245.
5. Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013; 339:966-971.
6. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data: or tears: an application to educational enrollments in states of India. Demography 2001; 38:115-132.
7. Swindale A, Bilinsky P. Development of a universally applicable household food insecurity measurement tool: process, current status, and outstanding issues. J Nutr 2006; 136: 1449S-1452S.
8. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974; 19:1-15.
9. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Int Med 1998; 158:1789-1795.
10. Tsai AC, Weiser SD, Steward WT, Mukiibi NF, Kawuma A, Kembabazi A, et al. Evidence for the reliability and validity of the internalized AIDS-related stigma scale in rural Uganda. AIDS Behav 2013; 17:427-433.
11. Venkatesh KK, Flanigan TP, Mayer KH. Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world. AIDS 2011; 25:1939-1949.
12. Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, Were W, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006; 20:85-92.
13. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA 2004; 292:224-236.
14. de Walque D, Kazianga H, Mead O. Antiretroviral therapy perceived efficacy and risky sexual behavior: Evidence from Mozambique. Eco Dev Cultur Change 2012; 61:97-126.
15. Kembabazi A, Bajunirwe F, Hunt PW, Martin JN, Muzoora C, Haberer JE, et al. Disinhibition in risky sexual behavior in men, but not women, during four years of antiretroviral therapy in rural, southwestern Uganda. PLoS ONE 2013; 8: e69634.
16. Durham MD, Buchacz K, Richardson J, Yang D, Wood K, Yangco B, et al. Sexual risk behavior and viremia among men who have sex with men in the HIV Outpatient Study (HOPS), USA, 2007-2010. J Acquir Immune Defic Syndr 2013; 63:372-378.
17. Tsai AC, Bangsberg DR, Kegeles SM, Katz IT, Haberer JE, Muzoora C, et al. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med 2013; 46:285-294.
18. Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS 2006; 20:359-368.
19. Schroder KE, Carey MP, Vanable PA. Methodological challenges in research on sexual risk behavior: I. Item content, scaling, and data analytical options. Ann Behav Med 2003; 26:76-103.
20. Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, et al. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr 2010; 53:405-411.